- Home
- NVGS vs PAHC Comparison
NVGS vs PAHC Comparison
Compare NVGS & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- PAHC
- Stock Information
- Founded
- NVGS 1997
- PAHC 1946
- Country
- NVGS United Kingdom
- PAHC United States
- Employees
- NVGS N/A
- PAHC N/A
- Industry
- NVGS Marine Transportation
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- NVGS Consumer Discretionary
- PAHC Health Care
- Exchange
- NVGS Nasdaq
- PAHC Nasdaq
- Market Cap
- NVGS 957.8M
- PAHC 946.9M
- IPO Year
- NVGS N/A
- PAHC 2014
- Fundamental
- Price
- NVGS $14.27
- PAHC $24.46
- Analyst Decision
- NVGS Strong Buy
- PAHC Sell
- Analyst Count
- NVGS 3
- PAHC 4
- Target Price
- NVGS $22.00
- PAHC $20.00
- AVG Volume (30 Days)
- NVGS 354.5K
- PAHC 288.4K
- Earning Date
- NVGS 05-14-2025
- PAHC 05-07-2025
- Dividend Yield
- NVGS 1.41%
- PAHC 1.97%
- EPS Growth
- NVGS 9.28
- PAHC 140.17
- EPS
- NVGS 1.27
- PAHC 0.78
- Revenue
- NVGS $583,931,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- NVGS $5.79
- PAHC $28.33
- Revenue Next Year
- NVGS N/A
- PAHC $13.78
- P/E Ratio
- NVGS $11.17
- PAHC $31.29
- Revenue Growth
- NVGS 6.38
- PAHC 19.12
- 52 Week Low
- NVGS $10.55
- PAHC $16.16
- 52 Week High
- NVGS $18.18
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- NVGS 59.03
- PAHC 65.23
- Support Level
- NVGS $13.50
- PAHC $22.51
- Resistance Level
- NVGS $14.44
- PAHC $25.26
- Average True Range (ATR)
- NVGS 0.40
- PAHC 0.86
- MACD
- NVGS 0.04
- PAHC 0.07
- Stochastic Oscillator
- NVGS 66.67
- PAHC 69.58
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture).
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.